Skip to main content
Erschienen in: Current Gastroenterology Reports 5/2012

01.10.2012 | Small Intestine (J Sellin, Section Editor)

Clinical Implications of Enteroadherent Escherichia coli

verfasst von: Margarita M. P. Arenas-Hernández, Ygnacio Martínez-Laguna, Alfredo G. Torres

Erschienen in: Current Gastroenterology Reports | Ausgabe 5/2012

Einloggen, um Zugang zu erhalten

Abstract

Pathogenic Escherichia coli that colonize the small intestine primarily cause gastrointestinal illness in infants and travelers. The main categories of pathogenic E. coli that colonize the epithelial lining of the small intestine are enterotoxigenic E. coli, enteropathogenic E. coli, and enteroaggregative E. coli. These organisms accomplish their pathogenic process by a complex, coordinated multistage strategy, including nonintimate adherence mediated by various adhesins. These so called “enteroadherent E. coli” categories subsequently produce toxins or effector proteins that are either secreted to the milieu or injected to the host cell. Finally, destruction of the intestinal microvilli results from the intimate adherence or the toxic effect exerted over the epithelia, resulting in water secretion and diarrhea. In this review, we summarize the current state of knowledge regarding these enteroadherent E. coli strains and the present clinical understanding of how these organisms colonize the human intestine and cause disease.
Literatur
1.
Zurück zum Zitat Torres AG, Zhou X, Kaper JB. Adherence of diarrheagenic Escherichia coli strains to epithelial cells. Infect Immun. 2005;73:18–29.PubMedCrossRef Torres AG, Zhou X, Kaper JB. Adherence of diarrheagenic Escherichia coli strains to epithelial cells. Infect Immun. 2005;73:18–29.PubMedCrossRef
2.
Zurück zum Zitat Kaper JB, Nataro JP, Mobley HLT. Pathogenic Escherichia coli. Nat Rev Microbiol. 2004;2:123–40.PubMedCrossRef Kaper JB, Nataro JP, Mobley HLT. Pathogenic Escherichia coli. Nat Rev Microbiol. 2004;2:123–40.PubMedCrossRef
3.
Zurück zum Zitat WHO. Future Directions for Research on Enterotoxigenic Escherichia coli Vaccines for Developing Countries. Wkly Epidemiol Rec. 2006;81:97–104. WHO. Future Directions for Research on Enterotoxigenic Escherichia coli Vaccines for Developing Countries. Wkly Epidemiol Rec. 2006;81:97–104.
4.
Zurück zum Zitat Wang M, Szucs TD, Steffen R. Economic aspects of travelers’ diarrhea. J Travel Med. 2008;15:110–8.PubMedCrossRef Wang M, Szucs TD, Steffen R. Economic aspects of travelers’ diarrhea. J Travel Med. 2008;15:110–8.PubMedCrossRef
5.
Zurück zum Zitat Qadri F, Saha A, Ahmed T, Al Tarique A, Begum YA, Svennerholm AM. Disease burden due to enterotoxigenic Escherichia coli in the first 2 years of life in an urban community in Bangladesh. Infect Immun. 2007;75:3961–8.PubMedCrossRef Qadri F, Saha A, Ahmed T, Al Tarique A, Begum YA, Svennerholm AM. Disease burden due to enterotoxigenic Escherichia coli in the first 2 years of life in an urban community in Bangladesh. Infect Immun. 2007;75:3961–8.PubMedCrossRef
6.
Zurück zum Zitat Fleckenstein JM, Hardwidge PR, Munson GP, Rasko DA, Sommerfelt H, Steinsland H. Molecular mechanisms of enterotoxigenic Escherichia coli infection. Microbes Infect. 2010;12:89–98.PubMedCrossRef Fleckenstein JM, Hardwidge PR, Munson GP, Rasko DA, Sommerfelt H, Steinsland H. Molecular mechanisms of enterotoxigenic Escherichia coli infection. Microbes Infect. 2010;12:89–98.PubMedCrossRef
7.
Zurück zum Zitat Qadri F, Svennerholm AM, Faruque AS, Sack RB. Enterotoxigenic Escherichia coli in developing countries: epidemiology, microbiology, clinical features, treatment, and prevention. Clin Microbiol Rev. 2005;18:465–83.PubMedCrossRef Qadri F, Svennerholm AM, Faruque AS, Sack RB. Enterotoxigenic Escherichia coli in developing countries: epidemiology, microbiology, clinical features, treatment, and prevention. Clin Microbiol Rev. 2005;18:465–83.PubMedCrossRef
8.
Zurück zum Zitat Svennerholm AM, Tobias J. Vaccines against enterotoxigenic Escherichia coli. Expert Rev Vaccines. 2008;7:795–804.PubMedCrossRef Svennerholm AM, Tobias J. Vaccines against enterotoxigenic Escherichia coli. Expert Rev Vaccines. 2008;7:795–804.PubMedCrossRef
9.
Zurück zum Zitat Gaastra W, Svennerholm AM. Colonization factors of human enterotoxigenic Escherichia coli (ETEC). Trends Microbiol. 1996;4:444–52.PubMedCrossRef Gaastra W, Svennerholm AM. Colonization factors of human enterotoxigenic Escherichia coli (ETEC). Trends Microbiol. 1996;4:444–52.PubMedCrossRef
10.
Zurück zum Zitat Turner SM, Scott-Tucker A, Cooper LM, Henderson IR. Weapons of mass destruction: virulence factors of the global killer enterotoxigenic Escherichia coli. FEMS Microbiol Lett. 2006;263:10–20.PubMedCrossRef Turner SM, Scott-Tucker A, Cooper LM, Henderson IR. Weapons of mass destruction: virulence factors of the global killer enterotoxigenic Escherichia coli. FEMS Microbiol Lett. 2006;263:10–20.PubMedCrossRef
11.
Zurück zum Zitat Dorsey FC, Fischer JF, Fleckenstein JM. Directed delivery of heat-labile enterotoxin by enterotoxigenic Escherichia coli. Cell Microbiol. 2006;8:1516–27.PubMedCrossRef Dorsey FC, Fischer JF, Fleckenstein JM. Directed delivery of heat-labile enterotoxin by enterotoxigenic Escherichia coli. Cell Microbiol. 2006;8:1516–27.PubMedCrossRef
12.
Zurück zum Zitat Johnson AM, Kaushik RS, Francis DH, Fleckenstein JM, Hardwidge PR. Heat-labile enterotoxin promotes Escherichia coli adherence to intestinal epithelial cells. J Bacteriol. 2009;191:178–86.PubMedCrossRef Johnson AM, Kaushik RS, Francis DH, Fleckenstein JM, Hardwidge PR. Heat-labile enterotoxin promotes Escherichia coli adherence to intestinal epithelial cells. J Bacteriol. 2009;191:178–86.PubMedCrossRef
13.
Zurück zum Zitat Lasaro MA, Mathias-Santos C, Rodrigues JF, Ferreira LC. Functional and immunological characterization of a natural polymorphic variant of a heat-labile toxin (LT-I) produced by enterotoxigenic Escherichia coli (ETEC). FEMS Immunol Med Microbiol. 2009;55:93–9.PubMedCrossRef Lasaro MA, Mathias-Santos C, Rodrigues JF, Ferreira LC. Functional and immunological characterization of a natural polymorphic variant of a heat-labile toxin (LT-I) produced by enterotoxigenic Escherichia coli (ETEC). FEMS Immunol Med Microbiol. 2009;55:93–9.PubMedCrossRef
14.
Zurück zum Zitat Yoder JS, Cesario S, Plotkin V, Ma X, Kelly-Shannon K, Dworkin MS. Outbreak of enterotoxigenic Escherichia coli infection with an unusually long duration of illness. Clin Infect Dis. 2006;42:1513–7.PubMedCrossRef Yoder JS, Cesario S, Plotkin V, Ma X, Kelly-Shannon K, Dworkin MS. Outbreak of enterotoxigenic Escherichia coli infection with an unusually long duration of illness. Clin Infect Dis. 2006;42:1513–7.PubMedCrossRef
15.
Zurück zum Zitat Hill DR. Occurrence and self-treatment of diarrhea in a large cohort of Americans traveling to developing countries. AmJTrop Med Hyg. 2000;62:585–9. Hill DR. Occurrence and self-treatment of diarrhea in a large cohort of Americans traveling to developing countries. AmJTrop Med Hyg. 2000;62:585–9.
16.
Zurück zum Zitat Steffen R, Castelli F, Dieter Nothdurft H, Rombo L, Jane Zuckerman N. Vaccination against enterotoxigenic Escherichia coli, a cause of travellers’ diarrhea. J Travel Med. 2005;12:102–7.PubMedCrossRef Steffen R, Castelli F, Dieter Nothdurft H, Rombo L, Jane Zuckerman N. Vaccination against enterotoxigenic Escherichia coli, a cause of travellers’ diarrhea. J Travel Med. 2005;12:102–7.PubMedCrossRef
17.
Zurück zum Zitat Sack DA, Shimko J, Torres O, Bourgeois AL, Francia DS, Gustafsson B, et al. Randomised, double-blind, safety and efficacy of a killed oral vaccine for enterotoxigenic E. coli diarrhea of travellers to Guatemala and Mexico. Vaccine. 2007;25:4392–400.PubMedCrossRef Sack DA, Shimko J, Torres O, Bourgeois AL, Francia DS, Gustafsson B, et al. Randomised, double-blind, safety and efficacy of a killed oral vaccine for enterotoxigenic E. coli diarrhea of travellers to Guatemala and Mexico. Vaccine. 2007;25:4392–400.PubMedCrossRef
18.
Zurück zum Zitat DuPont HL, Haynes GA, Pickering LK, Tjoa W, Sullivan P, Olarte J. Diarrhea of travelers to Mexico. Relative susceptibility of United States and Latin American students attending a Mexican University. Am J Epidemiol. 1977;105:37–41.PubMed DuPont HL, Haynes GA, Pickering LK, Tjoa W, Sullivan P, Olarte J. Diarrhea of travelers to Mexico. Relative susceptibility of United States and Latin American students attending a Mexican University. Am J Epidemiol. 1977;105:37–41.PubMed
19.
Zurück zum Zitat Svennerholm AM. From cholera to enterotoxigenic Escherichia coli (ETEC) vaccine development. Indian J Med Res. 2011;133:188–94.PubMed Svennerholm AM. From cholera to enterotoxigenic Escherichia coli (ETEC) vaccine development. Indian J Med Res. 2011;133:188–94.PubMed
20.
Zurück zum Zitat • Harro C, Sack D, Bourgeois AL, Walker R, DeNearing B, Feller A, et al. Combination vaccine consisting of three live attenuated enterotoxigenic Escherichia coli strains expressing a range of colonization factors and heat-labile toxin subunit B is well tolerated and immunogenic in a placebo-controlled double-blind phase I trial in healthy adults. Clin Vaccine Immunol. 2011;18:2118–27. This report describes the safety and immunogenicity results from the first-in-human dose-escalation trial of ACE527, a three live attenuated ETEC vaccine strains that collectively express several CSs and LTB. PubMedCrossRef • Harro C, Sack D, Bourgeois AL, Walker R, DeNearing B, Feller A, et al. Combination vaccine consisting of three live attenuated enterotoxigenic Escherichia coli strains expressing a range of colonization factors and heat-labile toxin subunit B is well tolerated and immunogenic in a placebo-controlled double-blind phase I trial in healthy adults. Clin Vaccine Immunol. 2011;18:2118–27. This report describes the safety and immunogenicity results from the first-in-human dose-escalation trial of ACE527, a three live attenuated ETEC vaccine strains that collectively express several CSs and LTB. PubMedCrossRef
21.
Zurück zum Zitat • Crossman LC, Chaudhuri RR, Beatson SA, Wells TJ, Desvaux M, Cunningham AF, et al. A commensal gone bad: complete genome sequence of the prototypical enterotoxigenic Escherichia coli strain H10407. J Bacteriol. 2010;192:822–31. This paper describes for the first time the complete genomic sequence of E. coli H10407, a prototypical strain of enterotoxigenic E. coli. CrossRef • Crossman LC, Chaudhuri RR, Beatson SA, Wells TJ, Desvaux M, Cunningham AF, et al. A commensal gone bad: complete genome sequence of the prototypical enterotoxigenic Escherichia coli strain H10407. J Bacteriol. 2010;192:822–31. This paper describes for the first time the complete genomic sequence of E. coli H10407, a prototypical strain of enterotoxigenic E. coli. CrossRef
22.
Zurück zum Zitat Harris JA, Roy K, Woo-Rasberry V, Hamilton DJ, Kansal R, Qadri F, et al. Directed evaluation of enterotoxigenic Escherichia coli autotransporter proteins as putative vaccine candidates. PLoS Negl Trop Dis. 2011;5:e1428.PubMedCrossRef Harris JA, Roy K, Woo-Rasberry V, Hamilton DJ, Kansal R, Qadri F, et al. Directed evaluation of enterotoxigenic Escherichia coli autotransporter proteins as putative vaccine candidates. PLoS Negl Trop Dis. 2011;5:e1428.PubMedCrossRef
23.
Zurück zum Zitat Wagner A, Wiedermann U. Travellers’ diarrhoea—pros and cons of different prophylactic measures. Wien Klin Wochenschr. 2009;121:13–8.PubMedCrossRef Wagner A, Wiedermann U. Travellers’ diarrhoea—pros and cons of different prophylactic measures. Wien Klin Wochenschr. 2009;121:13–8.PubMedCrossRef
24.
Zurück zum Zitat Frech SA, Dupont HL, Bourgeois AL, McKenzie R, Belkind-Gerson J, Figueroa JF, et al. Use of a patch containing heat-labile toxin from Escherichia coli against travellers’ diarrhoea: a phase II, randomised, double-blind, placebo-controlled field trial. Lancet. 2008;371:2019–25.PubMedCrossRef Frech SA, Dupont HL, Bourgeois AL, McKenzie R, Belkind-Gerson J, Figueroa JF, et al. Use of a patch containing heat-labile toxin from Escherichia coli against travellers’ diarrhoea: a phase II, randomised, double-blind, placebo-controlled field trial. Lancet. 2008;371:2019–25.PubMedCrossRef
25.
Zurück zum Zitat Flores J, Okhuysen PC. Enterotoxigenic Escherichia coli. In: Torres AG, editor. Pathogenic Escherichia coli in Latin America. Bentham Sciencie Publishers Ltd.; 2010. pp. 84–94. Flores J, Okhuysen PC. Enterotoxigenic Escherichia coli. In: Torres AG, editor. Pathogenic Escherichia coli in Latin America. Bentham Sciencie Publishers Ltd.; 2010. pp. 84–94.
26.
Zurück zum Zitat • Koo HL, DuPont HL. Rifaximin: a unique gastrointestinal-selective antibiotic for enteric diseases. Curr Opin Gastroenterol. 2010;26:17–25. This review describes the most recent advances in rifaximin treatment and prevention of travelers’ diarrhea. PubMedCrossRef • Koo HL, DuPont HL. Rifaximin: a unique gastrointestinal-selective antibiotic for enteric diseases. Curr Opin Gastroenterol. 2010;26:17–25. This review describes the most recent advances in rifaximin treatment and prevention of travelers’ diarrhea. PubMedCrossRef
27.
Zurück zum Zitat Koo HL, DuPont HL, Huang DB. The role of rifaximin in the treatment and chemoprophylaxis of travelers’ diarrhea. Ther Clin Risk Manag. 2009;5:841–8.PubMed Koo HL, DuPont HL, Huang DB. The role of rifaximin in the treatment and chemoprophylaxis of travelers’ diarrhea. Ther Clin Risk Manag. 2009;5:841–8.PubMed
28.
Zurück zum Zitat Lapointe TK, O’Connor PM, Buret AG. The role of epithelial malfunction in the pathogenesis of enteropathogenic E. coli-induced diarrea. Lab Invest. 2009;89:964–70.PubMedCrossRef Lapointe TK, O’Connor PM, Buret AG. The role of epithelial malfunction in the pathogenesis of enteropathogenic E. coli-induced diarrea. Lab Invest. 2009;89:964–70.PubMedCrossRef
29.
Zurück zum Zitat Wong AR, Pearson JS, Bright MD, Munera D, Robinson KS, Lee SF, et al. Enteropathogenic and enterohaemorrhagic Escherichia coli: even more subversive elements. Mol Microbiol. 2011;80:1420–38.PubMedCrossRef Wong AR, Pearson JS, Bright MD, Munera D, Robinson KS, Lee SF, et al. Enteropathogenic and enterohaemorrhagic Escherichia coli: even more subversive elements. Mol Microbiol. 2011;80:1420–38.PubMedCrossRef
30.
Zurück zum Zitat Bardiau M, Szalo M, Mainil JG. Initial adherence of EPEC, EHEC and VTEC to host cells. Vet Res. 2010;41:57.PubMedCrossRef Bardiau M, Szalo M, Mainil JG. Initial adherence of EPEC, EHEC and VTEC to host cells. Vet Res. 2010;41:57.PubMedCrossRef
31.
Zurück zum Zitat Humphries RM, Armstrong GD. Sticky situation: localized adherence of enteropathogenic Escherichia coli to the small intestine epithelium. Future Microbiol. 2010;5:1645–61.PubMedCrossRef Humphries RM, Armstrong GD. Sticky situation: localized adherence of enteropathogenic Escherichia coli to the small intestine epithelium. Future Microbiol. 2010;5:1645–61.PubMedCrossRef
32.
Zurück zum Zitat Gomes TAT, Gonzalez-Pedrajo B. Enteropathogenic Escherichia coli (EPEC). In: Torres AG, editor. Pathogenic Escherichia coli in Latin America.: Betham Science Publishers Ltd; 2010. pp. 25–47. Gomes TAT, Gonzalez-Pedrajo B. Enteropathogenic Escherichia coli (EPEC). In: Torres AG, editor. Pathogenic Escherichia coli in Latin America.: Betham Science Publishers Ltd; 2010. pp. 25–47.
33.
Zurück zum Zitat Hernandes RT, Elias WP, Vieira MAM, Gomes TAT. An overview of atypical enteropathogenic Escherichia coli. FEMS Microbiol Lett. 2009;297:137–49.PubMedCrossRef Hernandes RT, Elias WP, Vieira MAM, Gomes TAT. An overview of atypical enteropathogenic Escherichia coli. FEMS Microbiol Lett. 2009;297:137–49.PubMedCrossRef
34.
Zurück zum Zitat Scaletsky ICA, Souza TB, Aranda KRS, Okeke IN. Genetic elements associated with antimicrobial resistance in enteropathogenic Escherichia coli (EPEC) from Brazil. BMC Microbiol. 2010;10:25.PubMedCrossRef Scaletsky ICA, Souza TB, Aranda KRS, Okeke IN. Genetic elements associated with antimicrobial resistance in enteropathogenic Escherichia coli (EPEC) from Brazil. BMC Microbiol. 2010;10:25.PubMedCrossRef
35.
Zurück zum Zitat • Ochoa TJ, Contreras CA. Enteropathogenic Escherichia coli infection in children. Curr Opin Infect Dis. 2011;24:478–83. This review discussed the current knowledge about atypical EPEC as a human pathogen. PubMedCrossRef • Ochoa TJ, Contreras CA. Enteropathogenic Escherichia coli infection in children. Curr Opin Infect Dis. 2011;24:478–83. This review discussed the current knowledge about atypical EPEC as a human pathogen. PubMedCrossRef
36.
Zurück zum Zitat Bugarel M, Martin A, Fach P, Beutin L. Virulence gene profiling of enterohemorrhagic (EHEC) and enteropathogenic (EPEC) Escherichia coli strains: a basis for molecular risk assessment of typical and atypical EPEC strains. BMC Microbiol. 2011;11:142.PubMedCrossRef Bugarel M, Martin A, Fach P, Beutin L. Virulence gene profiling of enterohemorrhagic (EHEC) and enteropathogenic (EPEC) Escherichia coli strains: a basis for molecular risk assessment of typical and atypical EPEC strains. BMC Microbiol. 2011;11:142.PubMedCrossRef
37.
Zurück zum Zitat Croxen MA, Finlay BB. Molecular mechanisms of Escherichia coli pathogenicity. Nat Rev Microbiol. 2010;8:26–38.PubMed Croxen MA, Finlay BB. Molecular mechanisms of Escherichia coli pathogenicity. Nat Rev Microbiol. 2010;8:26–38.PubMed
38.
Zurück zum Zitat • Calderon Toledo C, Arvidsson I, Karpman D. Cross-reactive protection against enterohemorrhagic Escherichia coli infection by enteropathogenic E. coli in a mouse model. Infect Immun. 2011;79:2224–33. Using a murine model of infection, this study shows that enteropathogenic E. coli infections may protect against enterohemorrhagic E. coli infections. PubMedCrossRef • Calderon Toledo C, Arvidsson I, Karpman D. Cross-reactive protection against enterohemorrhagic Escherichia coli infection by enteropathogenic E. coli in a mouse model. Infect Immun. 2011;79:2224–33. Using a murine model of infection, this study shows that enteropathogenic E. coli infections may protect against enterohemorrhagic E. coli infections. PubMedCrossRef
39.
Zurück zum Zitat Pawlowski SW, Warren CA, Guerrant R. Diagnosis and treatment of acute or persistent diarrhea. Gastroenterology. 2009;136:1874–86.PubMedCrossRef Pawlowski SW, Warren CA, Guerrant R. Diagnosis and treatment of acute or persistent diarrhea. Gastroenterology. 2009;136:1874–86.PubMedCrossRef
40.
Zurück zum Zitat Hodges K, Gill R. Infectious diarrea. Cellular and molecular mechanisms. Gut Microb. 2010;1:4–21.CrossRef Hodges K, Gill R. Infectious diarrea. Cellular and molecular mechanisms. Gut Microb. 2010;1:4–21.CrossRef
41.
Zurück zum Zitat Abba K, Sinfield R, Hart CA, Garner P. Pathogens associated with persistent diarrhea in children in low and middle income countries: systematic review. BMC Infect Dis. 2009;9:88.PubMedCrossRef Abba K, Sinfield R, Hart CA, Garner P. Pathogens associated with persistent diarrhea in children in low and middle income countries: systematic review. BMC Infect Dis. 2009;9:88.PubMedCrossRef
42.
Zurück zum Zitat García PG, Silva VL, Dinis CG. Ocurrence and antimicrobial Drug Susceptibility Patterns of commensal and diarrheagenic Escherichia coli in fecal microbiota from children with and without acute diarrhea. J Microbiol. 2011;49:46–52.PubMedCrossRef García PG, Silva VL, Dinis CG. Ocurrence and antimicrobial Drug Susceptibility Patterns of commensal and diarrheagenic Escherichia coli in fecal microbiota from children with and without acute diarrhea. J Microbiol. 2011;49:46–52.PubMedCrossRef
43.
Zurück zum Zitat Ochoa TJ, Barletta F, Contreras C, Mercado E. New insights into the epidemiology of enteropathogenic Escherichia coli infection. Trans R Soc Trop Med Hyg. 2008;102:852–6.PubMedCrossRef Ochoa TJ, Barletta F, Contreras C, Mercado E. New insights into the epidemiology of enteropathogenic Escherichia coli infection. Trans R Soc Trop Med Hyg. 2008;102:852–6.PubMedCrossRef
44.
Zurück zum Zitat Fagundes-Neto U, Scaletsky IC. The gut at war: the consequences of enteropathogenic Escherichia coli infection as a factor of diarrhea and malnutrition. Sao Paulo Med J. 2000;118:21–9.PubMedCrossRef Fagundes-Neto U, Scaletsky IC. The gut at war: the consequences of enteropathogenic Escherichia coli infection as a factor of diarrhea and malnutrition. Sao Paulo Med J. 2000;118:21–9.PubMedCrossRef
45.
Zurück zum Zitat Liu ZH, Shen TY, Zhang P, Ma YL, Moyer MP, Qin HL. Protective effects of Lactobacillus plantarum against epithelial barrier dysfunction of human colon cell line NCM460. World J Gastroenterol. 2010;16:5759–65.PubMedCrossRef Liu ZH, Shen TY, Zhang P, Ma YL, Moyer MP, Qin HL. Protective effects of Lactobacillus plantarum against epithelial barrier dysfunction of human colon cell line NCM460. World J Gastroenterol. 2010;16:5759–65.PubMedCrossRef
46.
Zurück zum Zitat Britton RA, Versalovic J. Probiotics and gastrointestinal infections. Interdiscip Perspect Infect Dis. 2008;2008:290769.PubMed Britton RA, Versalovic J. Probiotics and gastrointestinal infections. Interdiscip Perspect Infect Dis. 2008;2008:290769.PubMed
47.
Zurück zum Zitat Hardegen C, Messler S, Henrich B, Pfeffer K, Würthner J, MacKenzie CR. A set of novel multiplex Taqman real-time PCRs for the detection of diarrhoeagenic Escherichia coli and its use in determining the prevalence of EPEC and EAEC in a university hospital. Ann Clin Microbiol Antimicrob. 2010;9:5.PubMedCrossRef Hardegen C, Messler S, Henrich B, Pfeffer K, Würthner J, MacKenzie CR. A set of novel multiplex Taqman real-time PCRs for the detection of diarrhoeagenic Escherichia coli and its use in determining the prevalence of EPEC and EAEC in a university hospital. Ann Clin Microbiol Antimicrob. 2010;9:5.PubMedCrossRef
48.
Zurück zum Zitat Mainil JG, Bardiau M, Ooka T, Ogura Y, Murase K, Etoh Y, et al. Typing of O26 enterohaemorrhagic and enteropathogenic Escherichia coli isolated from humans and cattle with IS621 multiplex PCR-based fingerprinting. J Appl Microbiol. 2011;111:773–86.PubMedCrossRef Mainil JG, Bardiau M, Ooka T, Ogura Y, Murase K, Etoh Y, et al. Typing of O26 enterohaemorrhagic and enteropathogenic Escherichia coli isolated from humans and cattle with IS621 multiplex PCR-based fingerprinting. J Appl Microbiol. 2011;111:773–86.PubMedCrossRef
49.
Zurück zum Zitat Bouzari S, Aslani MM, Oloomi M, Jafari A, Dashti A. Comparison of multiplex PCR with serogrouping and PCR-RFLP of fliC gene for the detection of enteropathogenic Escherichia coli (EPEC). Braz J Infect Dis. 2011;15:365–9.PubMed Bouzari S, Aslani MM, Oloomi M, Jafari A, Dashti A. Comparison of multiplex PCR with serogrouping and PCR-RFLP of fliC gene for the detection of enteropathogenic Escherichia coli (EPEC). Braz J Infect Dis. 2011;15:365–9.PubMed
50.
Zurück zum Zitat • Botkin DJ, Galli L, Sankarapani V, Soler M, Rivas M, Torres AG. Development of a Multiplex PCR Assay for detection of Shiga toxin-producing Escherichia coli, enterohemorrhagic E. coli, and enteropathogenic E. coli strains. Front Microbiol. 2012;2:1. This new mPCR methodology permitted the differentiation of enteropathogenic E. coli, Shiga toxin-producing E. coli, and enterohemorrhagic E. coli strains from other pathogenic E. coli. • Botkin DJ, Galli L, Sankarapani V, Soler M, Rivas M, Torres AG. Development of a Multiplex PCR Assay for detection of Shiga toxin-producing Escherichia coli, enterohemorrhagic E. coli, and enteropathogenic E. coli strains. Front Microbiol. 2012;2:1. This new mPCR methodology permitted the differentiation of enteropathogenic E. coli, Shiga toxin-producing E. coli, and enterohemorrhagic E. coli strains from other pathogenic E. coli.
51.
Zurück zum Zitat Flores J, Okhuysen PC. Enteroaggregative Escherichia coli infection. Curr Opin Gastroenterol. 2009;25:8–11.PubMedCrossRef Flores J, Okhuysen PC. Enteroaggregative Escherichia coli infection. Curr Opin Gastroenterol. 2009;25:8–11.PubMedCrossRef
52.
Zurück zum Zitat Harrington SM, Dudley EG, Nataro JP. Pathogenesis of enteroaggregative Escherichia coli infection. FEMS Microbiol Lett. 2006;254:12–8.PubMedCrossRef Harrington SM, Dudley EG, Nataro JP. Pathogenesis of enteroaggregative Escherichia coli infection. FEMS Microbiol Lett. 2006;254:12–8.PubMedCrossRef
53.
Zurück zum Zitat Weintraub A. Enteroaggregative Escherichia coli: epidemiology, virulence and detection. J Med Microbiol. 2007;56:4–8.PubMedCrossRef Weintraub A. Enteroaggregative Escherichia coli: epidemiology, virulence and detection. J Med Microbiol. 2007;56:4–8.PubMedCrossRef
54.
Zurück zum Zitat Andrade JA, Freymüller E, Fagundes-Neto U. Adherence of enteroaggregative Escherichia coli to the ileal and colonic mucosa: an in vitro study utilizing the scanning electron microscopy. Arq Gastroenterol. 2011;48:199–204.PubMedCrossRef Andrade JA, Freymüller E, Fagundes-Neto U. Adherence of enteroaggregative Escherichia coli to the ileal and colonic mucosa: an in vitro study utilizing the scanning electron microscopy. Arq Gastroenterol. 2011;48:199–204.PubMedCrossRef
55.
Zurück zum Zitat Dudley EG, Abe C, Ghigo JM, Latour-Lambert P, Hormazabul JC, Nataro JP. An IncI1 plasmid contributes to the adherence of the atypical enteroaggregative Escherichia coli strain C1096 to cultured cells and abiotic surfaces. Infect Immun. 2006;74:2102–14.PubMedCrossRef Dudley EG, Abe C, Ghigo JM, Latour-Lambert P, Hormazabul JC, Nataro JP. An IncI1 plasmid contributes to the adherence of the atypical enteroaggregative Escherichia coli strain C1096 to cultured cells and abiotic surfaces. Infect Immun. 2006;74:2102–14.PubMedCrossRef
56.
Zurück zum Zitat Abe CM, Knutton S, Pedroso MZ, Freymüller E, Gomes TA. An enteroaggregative Escherichia coli strain of serotype O111:H12 damages and invades cultured T84 cells and human colonic mucosa. FEMS Microbiol Lett. 2001;203:199–205.PubMedCrossRef Abe CM, Knutton S, Pedroso MZ, Freymüller E, Gomes TA. An enteroaggregative Escherichia coli strain of serotype O111:H12 damages and invades cultured T84 cells and human colonic mucosa. FEMS Microbiol Lett. 2001;203:199–205.PubMedCrossRef
57.
Zurück zum Zitat Pereira AC, Britto-Filho JD, de Carvalho JJ, das Gracas de Luna M, Rosa AC. Enteroaggregative Escherichia coli (EAEC) strains enter and survive within cultured epithelial cells. Microb Pathog. 2008;45:310–4.PubMedCrossRef Pereira AC, Britto-Filho JD, de Carvalho JJ, das Gracas de Luna M, Rosa AC. Enteroaggregative Escherichia coli (EAEC) strains enter and survive within cultured epithelial cells. Microb Pathog. 2008;45:310–4.PubMedCrossRef
58.
Zurück zum Zitat Sobieszczańska B, Duda AK, Turniak M, Duda-Madej A, Franiczek R, Kasprzykowska U. Characterization of genes associated with internalization of enteroaggregative Escherichia coli. Microb Pathog. 2011;50:141–7.PubMedCrossRef Sobieszczańska B, Duda AK, Turniak M, Duda-Madej A, Franiczek R, Kasprzykowska U. Characterization of genes associated with internalization of enteroaggregative Escherichia coli. Microb Pathog. 2011;50:141–7.PubMedCrossRef
59.
Zurück zum Zitat Konno T, Yatsuyanagi J, Saito S. Virulence gene profiling of enteroaggregative Escherichia coli heat-stable enterotoxin 1-harboring E. coli (EAST1EC) derived from sporadic diarrheal patients. FEMS Immunol Med Microbiol. 2011;[Epub ahead of print]. Konno T, Yatsuyanagi J, Saito S. Virulence gene profiling of enteroaggregative Escherichia coli heat-stable enterotoxin 1-harboring E. coli (EAST1EC) derived from sporadic diarrheal patients. FEMS Immunol Med Microbiol. 2011;[Epub ahead of print].
60.
Zurück zum Zitat Navarro-Garcia F. Enteroaggregative Escherichia coli plasmid-encoded toxin. Future Microbiol. 2010;5:1005–13.PubMedCrossRef Navarro-Garcia F. Enteroaggregative Escherichia coli plasmid-encoded toxin. Future Microbiol. 2010;5:1005–13.PubMedCrossRef
61.
Zurück zum Zitat Cappello RE, Estrada-Gutierrez G, Irles C, Giono-Cerezo S, Bloch RJ, Nataro JP. Effects of the plasmid-encoded toxin of enteroaggregative Escherichia coli on focal adhesion complexes. FEMS Immunol Med Microbiol. 2011;61:301–14.PubMedCrossRef Cappello RE, Estrada-Gutierrez G, Irles C, Giono-Cerezo S, Bloch RJ, Nataro JP. Effects of the plasmid-encoded toxin of enteroaggregative Escherichia coli on focal adhesion complexes. FEMS Immunol Med Microbiol. 2011;61:301–14.PubMedCrossRef
62.
Zurück zum Zitat • Boisen N, Scheutz F, Rasko DA, Redman JC, Persson S, Simon J, et al. Genomic characterization of enteroaggregative Escherichia coli from children in Mali. J Infect Dis. 2012;205:431–44. In this paper, an mPCR and comparative genome hybridization analysis of a collection of enteroaggregative E. coli (EAEC) strains was performed, and a subset of EAEC strains that are pathogenic was defined, including the identification of a marker for the most virulent isolates. PubMedCrossRef • Boisen N, Scheutz F, Rasko DA, Redman JC, Persson S, Simon J, et al. Genomic characterization of enteroaggregative Escherichia coli from children in Mali. J Infect Dis. 2012;205:431–44. In this paper, an mPCR and comparative genome hybridization analysis of a collection of enteroaggregative E. coli (EAEC) strains was performed, and a subset of EAEC strains that are pathogenic was defined, including the identification of a marker for the most virulent isolates. PubMedCrossRef
63.
Zurück zum Zitat • Edwards LA, Bajaj-Elliott M, Klein NJ, Murch SH, Phillips AD. Bacterial-epithelial contact is a key determinant of host innate immune responses to enteropathogenic and enteroaggregative Escherichia coli. PLoS One. 2011;6:e27030. This paper characterizes which bacterial motifs contribute to the innate epithelial response to enteropathogenic E. coli and enteroaggregative E. coli, using a range of E. coli isogenic mutant strains. PubMedCrossRef • Edwards LA, Bajaj-Elliott M, Klein NJ, Murch SH, Phillips AD. Bacterial-epithelial contact is a key determinant of host innate immune responses to enteropathogenic and enteroaggregative Escherichia coli. PLoS One. 2011;6:e27030. This paper characterizes which bacterial motifs contribute to the innate epithelial response to enteropathogenic E. coli and enteroaggregative E. coli, using a range of E. coli isogenic mutant strains. PubMedCrossRef
64.
Zurück zum Zitat • Boll EJ, Struve C, Sander A, Demma Z, Krogfelt KA, McCormick BA. Enteroaggregative Escherichia coli promotes transepithelial migration of neutrophils through a conserved 12-lipoxygenase pathway. Cell Microbiol. 2012;14:120–32. This paper found that polymorphonuclear neutrophils (PMN) transepithelial migration promoted enhanced attachment of enteroaggregative E. coli (EAEC) to T84 cells and suggested that EAEC-induced PMN infiltration may favor colonization and, thus, pathogenesis of EAEC. PubMedCrossRef • Boll EJ, Struve C, Sander A, Demma Z, Krogfelt KA, McCormick BA. Enteroaggregative Escherichia coli promotes transepithelial migration of neutrophils through a conserved 12-lipoxygenase pathway. Cell Microbiol. 2012;14:120–32. This paper found that polymorphonuclear neutrophils (PMN) transepithelial migration promoted enhanced attachment of enteroaggregative E. coli (EAEC) to T84 cells and suggested that EAEC-induced PMN infiltration may favor colonization and, thus, pathogenesis of EAEC. PubMedCrossRef
65.
Zurück zum Zitat Aslani MM, Alikhani MY, Zavari A, Yousefi R, Zamani AR. Characterization of enteroaggregative Escherichia coli (EAEC) clinical isolates and their antibiotic resistance pattern. Int J Infect Dis. 2011;15:e136–9.PubMedCrossRef Aslani MM, Alikhani MY, Zavari A, Yousefi R, Zamani AR. Characterization of enteroaggregative Escherichia coli (EAEC) clinical isolates and their antibiotic resistance pattern. Int J Infect Dis. 2011;15:e136–9.PubMedCrossRef
66.
Zurück zum Zitat Mortensen NP, Fowlkes JD, Maggart M, Doktycz MJ, Nataro JP, Drusano G, et al. Effects of sub-minimum inhibitory concentrations of ciprofloxacin on enteroaggregative Escherichia coli and the role of the surface protein dispersin. Int J Antimicrob Agents. 2011;38:27–34.PubMedCrossRef Mortensen NP, Fowlkes JD, Maggart M, Doktycz MJ, Nataro JP, Drusano G, et al. Effects of sub-minimum inhibitory concentrations of ciprofloxacin on enteroaggregative Escherichia coli and the role of the surface protein dispersin. Int J Antimicrob Agents. 2011;38:27–34.PubMedCrossRef
67.
Zurück zum Zitat Ouyang-Latimer J, Jafri S, VanTassel A, Jiang ZD, Gurleen K, Rodriguez S, et al. In vitro antimicrobial susceptibility of bacterial enteropathogens isolated from international travelers to Mexico, Guatemala, and India from 2006 to 2008. Antimicrob Agents Chemother. 2011;55:874–8.PubMedCrossRef Ouyang-Latimer J, Jafri S, VanTassel A, Jiang ZD, Gurleen K, Rodriguez S, et al. In vitro antimicrobial susceptibility of bacterial enteropathogens isolated from international travelers to Mexico, Guatemala, and India from 2006 to 2008. Antimicrob Agents Chemother. 2011;55:874–8.PubMedCrossRef
68.
Zurück zum Zitat Darfeuille-Michaud A. Adherent-invasive Escherichia coli: a putative new E. coli pathotype associated with Crohn’s disease. Int J Med Microbiol. 2002;292:185–93.PubMedCrossRef Darfeuille-Michaud A. Adherent-invasive Escherichia coli: a putative new E. coli pathotype associated with Crohn’s disease. Int J Med Microbiol. 2002;292:185–93.PubMedCrossRef
69.
Zurück zum Zitat Darfeuille-Michaud A, Boudeau J, Bulois P, Neut C, Glasser AL, Barnich N, et al. High prevalence of adherent-invasive Escherichia coli associated with ileal mucosa in Crohn’s disease. Gastroenterology. 2004;127:412–21.PubMedCrossRef Darfeuille-Michaud A, Boudeau J, Bulois P, Neut C, Glasser AL, Barnich N, et al. High prevalence of adherent-invasive Escherichia coli associated with ileal mucosa in Crohn’s disease. Gastroenterology. 2004;127:412–21.PubMedCrossRef
70.
Zurück zum Zitat Eaves-Pyles T, Allen CA, Taormina J, Swidsinski A, Tutt CB, Jezek GE, et al. Escherichia coli isolated from a Crohn’s disease patient adheres, invades, and induces inflammatory responses in polarized intestinal epithelial cells. Int J Med Microbiol. 2008;298:397–409.PubMedCrossRef Eaves-Pyles T, Allen CA, Taormina J, Swidsinski A, Tutt CB, Jezek GE, et al. Escherichia coli isolated from a Crohn’s disease patient adheres, invades, and induces inflammatory responses in polarized intestinal epithelial cells. Int J Med Microbiol. 2008;298:397–409.PubMedCrossRef
71.
Zurück zum Zitat Nash JH, Villegas A, Kropinski AM, Aguilar-Valenzuela R, Konczy P, Mascarenhas M, et al. Genome sequence of adherent-invasive Escherichia coli and comparative genomic analysis with other E. coli pathotypes. BMC Genomics. 2010;11:667.PubMedCrossRef Nash JH, Villegas A, Kropinski AM, Aguilar-Valenzuela R, Konczy P, Mascarenhas M, et al. Genome sequence of adherent-invasive Escherichia coli and comparative genomic analysis with other E. coli pathotypes. BMC Genomics. 2010;11:667.PubMedCrossRef
Metadaten
Titel
Clinical Implications of Enteroadherent Escherichia coli
verfasst von
Margarita M. P. Arenas-Hernández
Ygnacio Martínez-Laguna
Alfredo G. Torres
Publikationsdatum
01.10.2012
Verlag
Current Science Inc.
Erschienen in
Current Gastroenterology Reports / Ausgabe 5/2012
Print ISSN: 1522-8037
Elektronische ISSN: 1534-312X
DOI
https://doi.org/10.1007/s11894-012-0277-1

Weitere Artikel der Ausgabe 5/2012

Current Gastroenterology Reports 5/2012 Zur Ausgabe

Large Intestine (B Cash, Section Editor)

Update on Chronic Diarrhea: A Run-Through for the Clinician

Small Intestine (B Cash, Section Editor)

Advanced Colorectal Polyp Detection Techniques

Small Intestine (J Sellin, Section Editor)

Novel Treatments for NEC: Keeping IBD in Mind

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.